Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy

Leukemia and Lymphoma

Volumn 52, Issue 9, 2011, Pages 1704-1710

  Trelinska, Joanna ^a   Fendler, Wojciech ^a   Szadkowska, Agnieszka ^a   Czerwoniuk, Dorota ^a   Mianowska, Beata ^a   Wegner, Olga ^a   Mlynarski, Wojciech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

hepatotoxicity; Hypoglycemia; maintenance therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LIVER FUNCTION; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL;

ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOGLYCEMIA; MAINTENANCE CHEMOTHERAPY; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 80052062028     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.580024     Document Type: Article

References (22)

1. Bay A, Oner AF, Cesur Y, et al. Symptomatic hypoglycemia: an unusual side effect of oral purine analogues for treatment of ALL. Pediatr Blood Cancer 2006;47:330-331. (Pubitemid 44148052)
2. Ziino O, Russo D, Orlando MA, et al. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 2002;39:32-34. (Pubitemid 34556432)
3. Halonen P, Salo MK, Makipernaa A. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. J Pediatr 2001;138:428-431. (Pubitemid 32207152)
4. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med 2003;20:1012-1015. (Pubitemid 41701482)
5. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-938. (Pubitemid 36542603)
6. Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-1157. (Pubitemid 36929264)
7. Nawarycz T, Ostrowska-Nawarycz L. Body mass index in the school age children and youth from the city of Lodz. Pol Merkur Lekarski 2007;23:264-270.
8. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl. 1):11-61.
9. Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W. GlyCulator-a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol 2011;5:447-451.
10. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
11. Mohn A, Di Marzio A, Capanna R, et al. Persistence of impaired pancreatic beta-cell function in children treated for acute lymphoblastic leukemia. Lancet 2004;363:127-128. (Pubitemid 38068330)
12. Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002;16:225-243. (Pubitemid 35230786)
13. Janiszewski PM, Oeffinger KC, Church TS, et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metabol 2007;92:3816-3821. (Pubitemid 47607628)
14. Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G. Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Vasc Health Risk Manag 2008;4:825-836.
15. Trimis G, Moschovi M, Papassotiriou I, et al. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target preventing disease. J Pediatr Hematol Oncol 2007;29:309-314. (Pubitemid 46707511)
16. Roberts E, Ahluwalia MB, Lee G, et al. Resistance to hepatotoxins acquired by hepatocytes during liver regeneration. Cancer Res 1983;43:28-34. (Pubitemid 13172790)
17. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group,Fox LA, Beck RW, Xing D. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010;33:1297-1299.
18. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005;28:1245-1254.
19. Clarke W, Jones T, Rewers A, et al. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2009;10(Suppl. 12):134-145.
20. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008;36:3008-3013.
21. Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008;9:361-366.
22. Halonen P, Salo MK, Schmiegelow K. Investigation of the mechanism of therapy-related hypoglycemia in children with acute lymphoblastic leukaemia. Acta Paediatr 2003; 92:37-42. (Pubitemid 36255929)